Basmanav F Buket, Cesarato Nicole, Kumar Sheetal, Borisov Oleg, Kokordelis Pavlos, Ralser Damian J, Wehner Maria, Axt Daisy, Xiong Xing, Thiele Holger, Dolgin Vadim, Gossmann Yasmina, Fricker Nadine, Dewenter Malin Katharina, Weller Karsten, Suri Mohnish, Reichenbach Herbert, Oji Vinzenz, Addor Marie-Claude, Ramirez Karla, Stewart Helen, Garcia Bartels Natalie, Weibel Lisa, Wagner Nicola, George Susannah, Kilic Arzu, Tantcheva-Poor Iliana, Stewart Alison, Dikow Nicola, Blaumeiser Bettina, Medvecz Márta, Blume-Peytavi Ulrike, Farrant Paul, Grimalt Ramon, Bertok Sara, Bradley Lisa, Eskin-Schwartz Marina, Birk Ohad Samuel, Bygum Anette, Simon Michel, Krawitz Peter, Fischer Christine, Hamm Henning, Fritz Günter, Betz Regina C
Institute of Human Genetics, Medical Faculty & University Hospital Bonn, University of Bonn, Bonn, Germany.
Institute for Genomic Statistics and Bioinformatics, Medical Faculty & University Hospital Bonn, University of Bonn, Bonn, Germany.
JAMA Dermatol. 2022 Nov 1;158(11):1245-1253. doi: 10.1001/jamadermatol.2022.2319.
Uncombable hair syndrome (UHS) is a rare hair shaft anomaly that manifests during infancy and is characterized by dry, frizzy, and wiry hair that cannot be combed flat. Only about 100 known cases have been reported so far.
To elucidate the genetic spectrum of UHS.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study includes 107 unrelated index patients with a suspected diagnosis of UHS and family members who were recruited worldwide from January 2013 to December 2021. Participants of all ages, races, and ethnicities were recruited at referral centers or were enrolled on their own initiative following personal contact with the authors. Genetic analyses were conducted in Germany from January 2014 to December 2021.
Clinical photographs, Sanger or whole-exome sequencing and array-based genotyping of DNA extracted from blood or saliva samples, and 3-dimensional protein modeling. Descriptive statistics, such as frequency counts, were used to describe the distribution of identified pathogenic variants and genotypes.
The genetic characteristics of patients with UHS were established in 80 of 107 (74.8%) index patients (82 [76.6%] female) who carried biallelic pathogenic variants in PADI3, TGM3, or TCHH (ie, genes that encode functionally related hair shaft proteins). Molecular genetic findings from 11 of these 80 individuals were previously published. In 76 (71.0%) individuals, the UHS phenotype were associated with pathogenic variants in PADI3. The 2 most commonly observed PADI3 variants account for 73 (48.0%) and 57 (37.5%) of the 152 variant PADI3 alleles in total, respectively. Two individuals carried pathogenic variants in TGM3, and 2 others carried pathogenic variants in TCHH. Haplotype analyses suggested a founder effect for the 4 most commonly observed pathogenic variants in the PADI3 gene.
This cohort study extends and gives an overview of the genetic variant spectrum of UHS based on molecular genetic analyses of the largest worldwide collective of affected individuals, to our knowledge. Formerly, a diagnosis of UHS could only be made by physical examination of the patient and confirmed by microscopical examination of the hair shaft. The discovery of pathogenic variants in PADI3, TCHH, and TGM3 may open a new avenue for clinicians and affected individuals by introducing molecular diagnostics for UHS.
难梳理毛发综合征(UHS)是一种罕见的毛干异常疾病,在婴儿期出现,其特征为毛发干燥、卷曲且硬如钢丝,无法梳直。迄今为止,仅报告了约100例已知病例。
阐明UHS的基因谱。
设计、背景和参与者:这项队列研究纳入了107例疑似UHS的非亲属索引患者及其家庭成员,这些患者于2013年1月至2021年12月在全球范围内招募。所有年龄、种族和民族的参与者均在转诊中心招募,或在与作者个人联系后主动报名参加。2014年1月至2021年12月在德国进行基因分析。
临床照片、从血液或唾液样本中提取的DNA的桑格测序或全外显子组测序以及基于芯片的基因分型,以及三维蛋白质建模。使用描述性统计,如频数计数,来描述已鉴定的致病变异和基因型的分布。
在107例索引患者中的80例(74.8%)中确定了UHS患者的遗传特征(82例[76.6%]为女性),这些患者在PADI3、TGM3或TCHH(即编码功能相关毛干蛋白的基因)中携带双等位基因致病变异。这80例个体中11例的分子遗传学发现此前已发表。在76例(71.0%)个体中,UHS表型与PADI3中的致病变异相关。在总共152个PADI3变异等位基因中,最常观察到的2种PADI3变异分别占73个(48.0%)和57个(37.5%)。2例个体在TGM3中携带致病变异,另外2例在TCHH中携带致病变异。单倍型分析表明,PADI3基因中最常观察到的4种致病变异存在奠基者效应。
据我们所知,这项队列研究基于对全球最大的受影响个体群体的分子遗传学分析,扩展并概述了UHS的基因变异谱。以前,UHS的诊断只能通过对患者进行体格检查并通过毛干显微镜检查来确诊。PADI3、TCHH和TGM3中致病变异的发现可能通过引入UHS的分子诊断,为临床医生和受影响个体开辟一条新途径。